Intravenous Infusions Plc (GHSE: IIL)
Health Care · Pharmaceuticals · GH
GH₵0.55
+12.24% today · +1000.0% 1Y
Intravenous Infusions Plc (GHSE: IIL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.84M.
Over the last twelve months the share price has gained 1000.0%, trading between 0.05 and 0.86.
Tweenvest scores Intravenous Infusions Plc across four factors: quality 55/100, value 63/100, growth 0/100. Its strongest factor is value.
IIL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.84M
- Revenue (TTM)
- $574.89K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -0.60
- 52-week high
- GH₵0.86
- 52-week low
- GH₵0.05
- Avg volume (3M)
- —
- Shares outstanding
- 274.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ayr Wellness Inc.CNSX: AYR.A | $13.21M | CA$— | — |
| Indo-Bangla Pharmaceuticals LimitedDSE: IBP | $13.02M | Tk13.80 | -5.48% |
| Silco Pharmaceuticals LimitedDSE: SILCOPHL | $12.90M | Tk15.30 | -8.38% |
| Anebulo Pharmaceuticals, Inc.OTCPK: ANEB | $12.85M | $0.32 | -1.56% |
| FLUENT Corp.CNSX: FNT.U | $12.76M | $0.02 | -20.00% |
| Biogened S.A.WSE: BGD | $12.41M | zł19.90 | +0.51% |
| Krebs Biochemicals & Industries LimitedBSE: 524518 | $12.41M | Rs55.72 | -19.71% |
| Liven Pharma LimitedKASE: LIVEN | $12.40M | PKRs30.37 | -2.47% |
Figures last refreshed Oct 11, 2026.